Evidence based healthcare for pharmaceutical products
 |
 
|
Show overview
This conference provides a forum for individuals working in the pharma industry to hear the latest updates on the appraisal process and requirements from different HTA agencies. It will address the methods and processes needed to navigate health technology assessment in a number of countries.
Topics will include:
- HTA policy and practice in Europe, USA and rest of the World
- HTA in reimbursement decisions
- Cooperation between regulatory bodies and HTA agencies
- How to demonstrate comparative effectiveness and outcomes research
- Case studies of HTA policy, practice and assessment methods
- HTA for speciality and high priced drugs
The conference will be comprised of:
- 30+ speakers
- 20+ sessions
- Facilitated one to one partnering sessions with key networking targets
- Online networking tool
- Interactive panel sessions
